The strong beat and raised guidance signal accelerating volume adoption and operating leverage. Monitor upcoming 10-Q for cash flow trajectory and litigation expense trends; the stock may gap up on the guidance raise and margin inflection.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 1 $120.80entry
- T+1 · 7mo ago −1.34%α −1.00% · $119.18
- T+5 · 6mo ago +3.37%α +1.02% · $124.87
- T+20 · 6mo ago −9.63%α −14.91% · $109.17
- T+60 · 4mo ago −2.84%α −5.91% · $117.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus estimates of $194.1M and -$0.64. The company raised full-year 2026 revenue guidance to $875M-$885M and adjusted EBITDA margin to 12-13%, driven by volume growth and margin expansion across cardiology and primary care channels.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $199.4M vs consensus $194.1M (+2.7% beat)
- GAAP EPS -$0.43 vs consensus -$0.64 (32.8% beat on a loss basis)
- Revenue grew 25.7% YoY from $158.7M
- Gross margin expanded 210 bps to 70.9%
- Net loss improved to $13.9M from $30.7M YoY
- Adjusted EBITDA turned positive to $14.1M from -$2.6M YoY
- Raised FY2026 revenue guidance to $875M-$885M (prior undisclosed)
- Raised FY2026 adjusted EBITDA margin guidance to 12-13%
- Unrestricted cash and marketable securities $549.6M
Financial Impact
Revenue beat by ~$5.3M; EPS beat by $0.21 vs consensus; guidance raised by undisclosed amount
Risk Factors
- Patent litigation costs ($3.7M in Q1) remain an overhang
- Still GAAP-unprofitable with net loss of $13.9M
- Operating cash flow negative at -$26.2M in Q1
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3285439 |
Track record
31 reports on IRTC
7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
- Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
- Nov 5, 202611d ago 8-K Mixed 6/10 No price data
- Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
- Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers